Your browser doesn't support javascript.
loading
Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic.
Kearns, Jeffrey D; Bukhalid, Raghida; Sevecka, Mark; Tan, Gege; Gerami-Moayed, Nastaran; Werner, Shannon L; Kohli, Neeraj; Burenkova, Olga; Sloss, Callum M; King, Anne M; Fitzgerald, Jonathan B; Nielsen, Ulrik B; Wolf, Beni B.
Afiliação
  • Kearns JD; Merrimack Pharmaceuticals, Cambridge, Massachusetts. jkearns@merrimackpharma.com.
  • Bukhalid R; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Sevecka M; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Tan G; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Gerami-Moayed N; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Werner SL; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Kohli N; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Burenkova O; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Sloss CM; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • King AM; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Fitzgerald JB; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Nielsen UB; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Wolf BB; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
Mol Cancer Ther ; 14(7): 1625-36, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25911688
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Antitumorais Modelo de Xenoenxerto / Receptores ErbB / Anticorpos Monoclonais / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Antitumorais Modelo de Xenoenxerto / Receptores ErbB / Anticorpos Monoclonais / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2015 Tipo de documento: Article